Skip to main content
Quest Diagnostics

Unwinding With DDX41: A Case Presentation Regarding DDX41 and Its Germline Predisposition to Myeloid Neoplasms

Unwinding with DDX41: A case presentation regarding DDX41 and its germline predisposition to myeloid neoplasms

This on-demand webinar will discuss:

  - DDX41: the most common gene mutation in hereditary myeloid neoplasms in adults

  - A newly recognized WHO category: “Myeloid Neoplasms with Germline Predisposition”

  - How mutations predispose to myeloid and lymphoid neoplasms

  - Asymptomatic carriers and the importance regarding bone marrow transplant donor selection

 

 

This is a recording from a live webinar series in collaboration with The US Oncology Network (USON) that was held in the beginning of 2023.

 

Presenter(s):
Destiney Allen, PhD and Michael Van Ness, MD
Moderator(s):

Hilary Frayer, BS, CG(ASCP)cm, MB(ASCP) cm

Product Director, Hematopathology, Quest Diagnostics

Related content

Publication
Optical Genome Mapping in Acute Myeloid Leukemia: A Multicenter Evaluation
Publication
Analytical Validation and Performance Characteristics of a 48 Gene Next-generation Sequencing Panel for Detecting Potentially Actionable Genomic Alterations in Myeloid Neoplasms
On-Demand Webinar
Hemepath Master Class: Chronic lymphocytic leukemia CLL small lymphocytic lymphoma SLL
On-Demand Webinar
Hemepath Master Class Myeloid Neoplasms MPN MDS AML
Audio Podcast
Optimize Oncology Care with Clinical Pathways
On-Demand Webinar
Precision Medicine: Your Role in Advancing the Future of Cancer Care

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.